POZEN To Present at the UBS 2010 Global Life Sciences Conference
CHAPEL HILL, N.C.--([ BUSINESS WIRE ])--POZEN Inc. (NASDAQ: POZN) announced today that Elizabeth A. Cermak, the Companya™s Executive Vice President and Chief Commercial Officer, will present at the UBS 2010 Global Life Sciences Conference on Monday, September 20, 2010 at 2:30 p.m. (EDT), at the Grand Hyatt Hotel in New York City. Ms. Cermaka™s presentation will be webcast and archived on POZENa™s home page at [ www.pozen.com ].
About POZEN
POZEN Inc., headquartered in Chapel Hill, NC, is a pharmaceutical company committed to transforming medicine that transforms lives. Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. Moving forward, POZEN is poised to become a model 21st century pharmaceutical company dedicated to ensuring that they produce cost-effective, evidence-based medicines; take a fresh approach to sales, marketing and medical education; and deliver high-quality, affordable pharmaceuticals to their customers. The Companya™s common stock is traded on The NASDAQ Stock Market under the symbol aPOZNa. For more detailed company information, including copies of this and other press releases, please visit: [ www.pozen.com ].